Overview of clinical data referring to validation cohort patients
| Sample type . | Sex . | Median age, y . | ELN risk class . | BM blast abundance (%) . | Assay . |
|---|---|---|---|---|---|
| BM = 24 | Female = 6 Male = 18 | 55 | High = 7 Intermediate = 7 Low = 6 NA = 4 | 70 (20-90) | NanoString |
| Sample type . | Sex . | Median age, y . | ELN risk class . | BM blast abundance (%) . | Assay . |
|---|---|---|---|---|---|
| BM = 24 | Female = 6 Male = 18 | 55 | High = 7 Intermediate = 7 Low = 6 NA = 4 | 70 (20-90) | NanoString |